Skip to main
  1. Stocks
  2. Ernexa Therapeutics Inc
  3. P/E Ratio
ERNA

ERNA P/E Ratio

P/E Ratio as of Nov 11, 2026: -0.11

Average-0.1096
Median-0.1100
Minimum-0.1200
Maximum-0.1000
-0.11
0.02 (15.38%)past month
The P/E ratio for ERNA is -0.11 as of Nov 11, 2026. This represents a decrease of -47.62% compared to its 12-month average P/E ratio of -0.21. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.

Ernexa Therapeutics Inc P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)

Ernexa Therapeutics Inc’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Ernexa Therapeutics Inc to industry peers.

ERNA P/E Ratio Insights

See Ernexa Therapeutics Inc’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.

Start investing in ERNA

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

ERNA P/E Ratio Historic Data

DateStock priceP/E ratio
Nov 2, 2026$1.95-0.10
Oct 1, 2026$2.96-0.16
Sep 1, 2026$4.35-0.23
Aug 3, 2026$3.45-0.11
Jul 1, 2026$6.7042-0.22
Jun 1, 2026$9.12-0.30
May 1, 2026$3.8125-0.12
Apr 1, 2026$5.2625-0.17
Mar 2, 2026$7.0075-0.09
Feb 2, 2026$31.00-0.38
Jan 2, 2026$29.00-0.36

ERNA End of Year P/E Ratio

DateP/E ratioChange
2026-0.11-70.27%
2025-0.37+825.00%
2024-0.04-91.11%
2023-0.45+45.16%
2022-0.31-79.61%
2021-1.52—

FAQs About Ernexa Therapeutics Inc (ERNA) P/E ratio

The latest P/E ratio of ERNA is -0.11, as of Nov 11, 2026. This is calculated based on its current stock price and earnings per share (EPS).

Ernexa Therapeutics Inc’s last 12-month average P/E ratio is -0.21, compared to its current P/E ratio of -0.11. This reflects a decrease of -47.62%.

Ernexa Therapeutics Inc’s current P/E ratio of -0.11 is lower than its last 12-month average P/E of -0.21. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.

Ernexa Therapeutics Inc’s average P/E ratio over the last 3 years is -0.22. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.

Ernexa Therapeutics Inc’s average P/E ratio over the last 5 years is -0.37. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.

Ernexa Therapeutics Inc (ERNA)


ERNA P/E Ratio Insights

See Ernexa Therapeutics Inc’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.

Start investing in ERNA

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.
Uncover ERNA stock data and trends